BHC in the 13F filings
Bausch Health Cos Inc · CUSIP 071734107
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 5 Feb 2026
- Managers listing it
- 32
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 4 listed it in both
- Shares listed
- 26,821,350
- combined, among listed positions
- Reported value
- $186m
- combined, at the quarter end
Among the 92 comparable managers: 25 buyers (opened or added shares) and 4 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +12,125,309.
Managers listing BHC in Q4 2025
32 of 32 holders
Largest increases and reductions, by shares
Increases
- Arrowstreet Capital LPexisting position · 2,723,655 shares now+2,518,064
- Citadel Advisors LLCexisting position · 1,487,295 shares now+1,459,715
- Millennium Management LLCexisting position · 1,836,137 shares now+1,366,268
- Acadian Asset Management LLCexisting position · 2,210,403 shares now+1,274,915
- Point72 Asset Management LPexisting position · 1,359,740 shares now+1,089,740
Reductions
- Marshall Wace LLPexisting position · 604,481 shares now-208,598
- Verition Fund Management LLCexisting position · 22,127 shares now-149,446
- GAMCO Investors Incexisting position · 874,452 shares now-31,592
- Squarepoint Ops LLCexisting position · 78,715 shares now-23,205
New positions and exits
New (5)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2018 | 2 | $29m | n.a. | n.a. |
| Q3 2018 | 12 | $1.0bn | n.a. | n.a. |
| Q4 2018 | 14 | $718m | n.a. | n.a. |
| Q1 2019 | 13 | $1.1bn | n.a. | n.a. |
| Q2 2019 | 14 | $1.2bn | n.a. | n.a. |
| Q3 2019 | 10 | $982m | n.a. | n.a. |
| Q4 2019 | 10 | $1.5bn | n.a. | n.a. |
| Q1 2020 | 11 | $806m | n.a. | n.a. |
| Q2 2020 | 9 | $840m | n.a. | n.a. |
| Q3 2020 | 10 | $664m | n.a. | n.a. |
| Q4 2020 | 11 | $1.0bn | n.a. | n.a. |
| Q1 2021 | 12 | $2.3bn | n.a. | n.a. |
| Q2 2021 | 14 | $2.2bn | n.a. | n.a. |
| Q3 2021 | 10 | $2.0bn | n.a. | n.a. |
| Q4 2021 | 9 | $1.8bn | n.a. | n.a. |
| Q1 2022 | 13 | $1.5bn | n.a. | n.a. |
| Q2 2022 | 8 | $539m | n.a. | n.a. |
| Q3 2022 | 10 | $350m | n.a. | n.a. |
| Q4 2022 | 9 | $325m | n.a. | n.a. |
| Q1 2023 | 5 | $387m | n.a. | n.a. |
| Q2 2023 | 6 | $409m | n.a. | n.a. |
| Q3 2023 | 9 | $429m | n.a. | n.a. |
| Q4 2023 | 6 | $403m | 1 | 3 |
| Q1 2024 | 9 | $594m | 3 | 3 |
| Q2 2024 | 8 | $380m | 3 | 4 |
| Q3 2024 | 6 | $331m | 1 | 4 |
| Q4 2024 | 6 | $341m | 3 | 1 |
| Q1 2025 | 5 | $277m | 2 | 2 |
| Q2 2025 | 5 | $285m | 0 | 2 |
| Q3 2025 | 4 | $47m | 1 | 2 |
| Q4 2025 | 6 | $68m | 25 | 4 |
| Q1 2026 | 5 | $61m | 8 | 19 |
| Q2 2026 | 4 | $55m | 12 | 11 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BHC and LLY →BHC and JNJ →BHC and VRTX →Choose a stock to compare with BHC →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BHC, latest filings →Back to the 13F Explorer →